Global Non-animal Capsule Market Insights and Forecast to 2026

Publisher Name :
Date: 12-Aug-2020
No. of pages: 146
Inquire Before Buying

Non-animal Capsule market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-animal Capsule market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non-animal Capsule market is segmented into

- Type A (pH-9, Skin)

- Type B (pH-4.7, Bone)

Segment by Application, the Non-animal Capsule market is segmented into

- Pharmaceutical

- Health Supplements

- Others

Regional and Country-level Analysis

The Non-animal Capsule market is analysed and market size information is provided by regions (countries).

The key regions covered in the Non-animal Capsule market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Non-animal Capsule Market Share Analysis

Non-animal Capsule market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-animal Capsule business, the date to enter into the Non-animal Capsule market, Non-animal Capsule product introduction, recent developments, etc.

The major vendors covered:

- Catalent

- Aenova

- NBTY

- Procaps

- Patheon (Thermo Fisher Scientific)

- Guangdong Yichao

- EuroCaps

- Captek

- Strides Arcolab

- Capsugel

- Soft Gel Technologies

- Amway

- Sirio Pharma

- Baihe Biotech

- Ziguang Group

- Yuwang Group

- Donghai Pharm

- By-Health

Global Non-animal Capsule Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Non-animal Capsule Product Introduction
1.2 Market Segments
1.3 Key Non-animal Capsule Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Non-animal Capsule Market Size Growth Rate by Type
1.4.2 Type A (pH-9, Skin)
1.4.3 Type B (pH-4.7, Bone)
1.5 Market by Application
1.5.1 Global Non-animal Capsule Market Size Growth Rate by Application
1.5.2 Pharmaceutical
1.5.3 Health Supplements
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Non-animal Capsule Market Size, Estimates and Forecasts
2.1.1 Global Non-animal Capsule Revenue 2015-2026
2.1.2 Global Non-animal Capsule Sales 2015-2026
2.2 Global Non-animal Capsule, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Non-animal Capsule Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Non-animal Capsule Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Non-animal Capsule Competitor Landscape by Players
3.1 Non-animal Capsule Sales by Manufacturers
3.1.1 Non-animal Capsule Sales by Manufacturers (2015-2020)
3.1.2 Non-animal Capsule Sales Market Share by Manufacturers (2015-2020)
3.2 Non-animal Capsule Revenue by Manufacturers
3.2.1 Non-animal Capsule Revenue by Manufacturers (2015-2020)
3.2.2 Non-animal Capsule Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Non-animal Capsule Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Non-animal Capsule Revenue in 2019
3.2.5 Global Non-animal Capsule Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Non-animal Capsule Price by Manufacturers
3.4 Non-animal Capsule Manufacturing Base Distribution, Product Types
3.4.1 Non-animal Capsule Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-animal Capsule Product Type
3.4.3 Date of International Manufacturers Enter into Non-animal Capsule Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Non-animal Capsule Market Size by Type (2015-2020)
4.1.1 Global Non-animal Capsule Sales by Type (2015-2020)
4.1.2 Global Non-animal Capsule Revenue by Type (2015-2020)
4.1.3 Non-animal Capsule Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Non-animal Capsule Market Size Forecast by Type (2021-2026)
4.2.1 Global Non-animal Capsule Sales Forecast by Type (2021-2026)
4.2.2 Global Non-animal Capsule Revenue Forecast by Type (2021-2026)
4.2.3 Non-animal Capsule Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Non-animal Capsule Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Non-animal Capsule Market Size by Application (2015-2020)
5.1.1 Global Non-animal Capsule Sales by Application (2015-2020)
5.1.2 Global Non-animal Capsule Revenue by Application (2015-2020)
5.1.3 Non-animal Capsule Price by Application (2015-2020)
5.2 Non-animal Capsule Market Size Forecast by Application (2021-2026)
5.2.1 Global Non-animal Capsule Sales Forecast by Application (2021-2026)
5.2.2 Global Non-animal Capsule Revenue Forecast by Application (2021-2026)
5.2.3 Global Non-animal Capsule Price Forecast by Application (2021-2026)
6 North America
6.1 North America Non-animal Capsule by Country
6.1.1 North America Non-animal Capsule Sales by Country
6.1.2 North America Non-animal Capsule Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Non-animal Capsule Market Facts & Figures by Type
6.3 North America Non-animal Capsule Market Facts & Figures by Application
7 Europe
7.1 Europe Non-animal Capsule by Country
7.1.1 Europe Non-animal Capsule Sales by Country
7.1.2 Europe Non-animal Capsule Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-animal Capsule Market Facts & Figures by Type
7.3 Europe Non-animal Capsule Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Non-animal Capsule by Region
8.1.1 Asia Pacific Non-animal Capsule Sales by Region
8.1.2 Asia Pacific Non-animal Capsule Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Non-animal Capsule Market Facts & Figures by Type
8.3 Asia Pacific Non-animal Capsule Market Facts & Figures by Application
9 Latin America
9.1 Latin America Non-animal Capsule by Country
9.1.1 Latin America Non-animal Capsule Sales by Country
9.1.2 Latin America Non-animal Capsule Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Non-animal Capsule Market Facts & Figures by Type
9.3 Central & South America Non-animal Capsule Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Non-animal Capsule by Country
10.1.1 Middle East and Africa Non-animal Capsule Sales by Country
10.1.2 Middle East and Africa Non-animal Capsule Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Non-animal Capsule Market Facts & Figures by Type
10.3 Middle East and Africa Non-animal Capsule Market Facts & Figures by Application
11 Company Profiles
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description and Business Overview
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Non-animal Capsule Products Offered
11.1.5 Catalent Related Developments
11.2 Aenova
11.2.1 Aenova Corporation Information
11.2.2 Aenova Description and Business Overview
11.2.3 Aenova Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aenova Non-animal Capsule Products Offered
11.2.5 Aenova Related Developments
11.3 NBTY
11.3.1 NBTY Corporation Information
11.3.2 NBTY Description and Business Overview
11.3.3 NBTY Sales, Revenue and Gross Margin (2015-2020)
11.3.4 NBTY Non-animal Capsule Products Offered
11.3.5 NBTY Related Developments
11.4 Procaps
11.4.1 Procaps Corporation Information
11.4.2 Procaps Description and Business Overview
11.4.3 Procaps Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Procaps Non-animal Capsule Products Offered
11.4.5 Procaps Related Developments
11.5 Patheon (Thermo Fisher Scientific)
11.5.1 Patheon (Thermo Fisher Scientific) Corporation Information
11.5.2 Patheon (Thermo Fisher Scientific) Description and Business Overview
11.5.3 Patheon (Thermo Fisher Scientific) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Patheon (Thermo Fisher Scientific) Non-animal Capsule Products Offered
11.5.5 Patheon (Thermo Fisher Scientific) Related Developments
11.6 Guangdong Yichao
11.6.1 Guangdong Yichao Corporation Information
11.6.2 Guangdong Yichao Description and Business Overview
11.6.3 Guangdong Yichao Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Guangdong Yichao Non-animal Capsule Products Offered
11.6.5 Guangdong Yichao Related Developments
11.7 EuroCaps
11.7.1 EuroCaps Corporation Information
11.7.2 EuroCaps Description and Business Overview
11.7.3 EuroCaps Sales, Revenue and Gross Margin (2015-2020)
11.7.4 EuroCaps Non-animal Capsule Products Offered
11.7.5 EuroCaps Related Developments
11.8 Captek
11.8.1 Captek Corporation Information
11.8.2 Captek Description and Business Overview
11.8.3 Captek Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Captek Non-animal Capsule Products Offered
11.8.5 Captek Related Developments
11.9 Strides Arcolab
11.9.1 Strides Arcolab Corporation Information
11.9.2 Strides Arcolab Description and Business Overview
11.9.3 Strides Arcolab Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Strides Arcolab Non-animal Capsule Products Offered
11.9.5 Strides Arcolab Related Developments
11.10 Capsugel
11.10.1 Capsugel Corporation Information
11.10.2 Capsugel Description and Business Overview
11.10.3 Capsugel Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Capsugel Non-animal Capsule Products Offered
11.10.5 Capsugel Related Developments
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description and Business Overview
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Non-animal Capsule Products Offered
11.1.5 Catalent Related Developments
11.12 Amway
11.12.1 Amway Corporation Information
11.12.2 Amway Description and Business Overview
11.12.3 Amway Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Amway Products Offered
11.12.5 Amway Related Developments
11.13 Sirio Pharma
11.13.1 Sirio Pharma Corporation Information
11.13.2 Sirio Pharma Description and Business Overview
11.13.3 Sirio Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sirio Pharma Products Offered
11.13.5 Sirio Pharma Related Developments
11.14 Baihe Biotech
11.14.1 Baihe Biotech Corporation Information
11.14.2 Baihe Biotech Description and Business Overview
11.14.3 Baihe Biotech Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Baihe Biotech Products Offered
11.14.5 Baihe Biotech Related Developments
11.15 Ziguang Group
11.15.1 Ziguang Group Corporation Information
11.15.2 Ziguang Group Description and Business Overview
11.15.3 Ziguang Group Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Ziguang Group Products Offered
11.15.5 Ziguang Group Related Developments
11.16 Yuwang Group
11.16.1 Yuwang Group Corporation Information
11.16.2 Yuwang Group Description and Business Overview
11.16.3 Yuwang Group Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Yuwang Group Products Offered
11.16.5 Yuwang Group Related Developments
11.17 Donghai Pharm
11.17.1 Donghai Pharm Corporation Information
11.17.2 Donghai Pharm Description and Business Overview
11.17.3 Donghai Pharm Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Donghai Pharm Products Offered
11.17.5 Donghai Pharm Related Developments
11.18 By-Health
11.18.1 By-Health Corporation Information
11.18.2 By-Health Description and Business Overview
11.18.3 By-Health Sales, Revenue and Gross Margin (2015-2020)
11.18.4 By-Health Products Offered
11.18.5 By-Health Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Non-animal Capsule Market Estimates and Projections by Region
12.1.1 Global Non-animal Capsule Sales Forecast by Regions 2021-2026
12.1.2 Global Non-animal Capsule Revenue Forecast by Regions 2021-2026
12.2 North America Non-animal Capsule Market Size Forecast (2021-2026)
12.2.1 North America: Non-animal Capsule Sales Forecast (2021-2026)
12.2.2 North America: Non-animal Capsule Revenue Forecast (2021-2026)
12.2.3 North America: Non-animal Capsule Market Size Forecast by Country (2021-2026)
12.3 Europe Non-animal Capsule Market Size Forecast (2021-2026)
12.3.1 Europe: Non-animal Capsule Sales Forecast (2021-2026)
12.3.2 Europe: Non-animal Capsule Revenue Forecast (2021-2026)
12.3.3 Europe: Non-animal Capsule Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Non-animal Capsule Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Non-animal Capsule Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Non-animal Capsule Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Non-animal Capsule Market Size Forecast by Region (2021-2026)
12.5 Latin America Non-animal Capsule Market Size Forecast (2021-2026)
12.5.1 Latin America: Non-animal Capsule Sales Forecast (2021-2026)
12.5.2 Latin America: Non-animal Capsule Revenue Forecast (2021-2026)
12.5.3 Latin America: Non-animal Capsule Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Non-animal Capsule Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Non-animal Capsule Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Non-animal Capsule Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Non-animal Capsule Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Non-animal Capsule Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-animal Capsule Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Non-animal Capsule Market Segments
Table 2. Ranking of Global Top Non-animal Capsule Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Non-animal Capsule Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Type A (pH-9, Skin)
Table 5. Major Manufacturers of Type B (pH-4.7, Bone)
Table 6. Global Non-animal Capsule Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Non-animal Capsule Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Non-animal Capsule Sales by Regions 2015-2020 (K Units)
Table 9. Global Non-animal Capsule Sales Market Share by Regions (2015-2020)
Table 10. Global Non-animal Capsule Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Non-animal Capsule Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Non-animal Capsule Sales Share by Manufacturers (2015-2020)
Table 13. Global Non-animal Capsule Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Non-animal Capsule by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-animal Capsule as of 2019)
Table 15. Non-animal Capsule Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Non-animal Capsule Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Non-animal Capsule Price (2015-2020) (USD/Unit)
Table 18. Non-animal Capsule Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Non-animal Capsule Product Type
Table 20. Date of International Manufacturers Enter into Non-animal Capsule Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 23. Global Non-animal Capsule Sales Share by Type (2015-2020)
Table 24. Global Non-animal Capsule Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Non-animal Capsule Revenue Share by Type (2015-2020)
Table 26. Non-animal Capsule Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 28. Global Non-animal Capsule Sales Share by Application (2015-2020)
Table 29. North America Non-animal Capsule Sales by Country (2015-2020) (K Units)
Table 30. North America Non-animal Capsule Sales Market Share by Country (2015-2020)
Table 31. North America Non-animal Capsule Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Non-animal Capsule Revenue Market Share by Country (2015-2020)
Table 33. North America Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 34. North America Non-animal Capsule Sales Market Share by Type (2015-2020)
Table 35. North America Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 36. North America Non-animal Capsule Sales Market Share by Application (2015-2020)
Table 37. Europe Non-animal Capsule Sales by Country (2015-2020) (K Units)
Table 38. Europe Non-animal Capsule Sales Market Share by Country (2015-2020)
Table 39. Europe Non-animal Capsule Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Non-animal Capsule Revenue Market Share by Country (2015-2020)
Table 41. Europe Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 42. Europe Non-animal Capsule Sales Market Share by Type (2015-2020)
Table 43. Europe Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 44. Europe Non-animal Capsule Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Non-animal Capsule Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Non-animal Capsule Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Non-animal Capsule Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Non-animal Capsule Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Non-animal Capsule Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Non-animal Capsule Sales Market Share by Application (2015-2020)
Table 53. Latin America Non-animal Capsule Sales by Country (2015-2020) (K Units)
Table 54. Latin America Non-animal Capsule Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Non-animal Capsule Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Non-animal Capsule Revenue Market Share by Country (2015-2020)
Table 57. Latin America Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 58. Latin America Non-animal Capsule Sales Market Share by Type (2015-2020)
Table 59. Latin America Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 60. Latin America Non-animal Capsule Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Non-animal Capsule Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Non-animal Capsule Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Non-animal Capsule Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Non-animal Capsule Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Non-animal Capsule Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Non-animal Capsule Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Non-animal Capsule Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Non-animal Capsule Sales Market Share by Application (2015-2020)
Table 69. Catalent Corporation Information
Table 70. Catalent Description and Major Businesses
Table 71. Catalent Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Catalent Product
Table 73. Catalent Recent Development
Table 74. Aenova Corporation Information
Table 75. Aenova Description and Major Businesses
Table 76. Aenova Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Aenova Product
Table 78. Aenova Recent Development
Table 79. NBTY Corporation Information
Table 80. NBTY Description and Major Businesses
Table 81. NBTY Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. NBTY Product
Table 83. NBTY Recent Development
Table 84. Procaps Corporation Information
Table 85. Procaps Description and Major Businesses
Table 86. Procaps Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Procaps Product
Table 88. Procaps Recent Development
Table 89. Patheon (Thermo Fisher Scientific) Corporation Information
Table 90. Patheon (Thermo Fisher Scientific) Description and Major Businesses
Table 91. Patheon (Thermo Fisher Scientific) Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Patheon (Thermo Fisher Scientific) Product
Table 93. Patheon (Thermo Fisher Scientific) Recent Development
Table 94. Guangdong Yichao Corporation Information
Table 95. Guangdong Yichao Description and Major Businesses
Table 96. Guangdong Yichao Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Guangdong Yichao Product
Table 98. Guangdong Yichao Recent Development
Table 99. EuroCaps Corporation Information
Table 100. EuroCaps Description and Major Businesses
Table 101. EuroCaps Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. EuroCaps Product
Table 103. EuroCaps Recent Development
Table 104. Captek Corporation Information
Table 105. Captek Description and Major Businesses
Table 106. Captek Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Captek Product
Table 108. Captek Recent Development
Table 109. Strides Arcolab Corporation Information
Table 110. Strides Arcolab Description and Major Businesses
Table 111. Strides Arcolab Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Strides Arcolab Product
Table 113. Strides Arcolab Recent Development
Table 114. Capsugel Corporation Information
Table 115. Capsugel Description and Major Businesses
Table 116. Capsugel Non-animal Capsule Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Capsugel Product
Table 118. Capsugel Recent Development
Table 119. Soft Gel Technologies Corporation Information
Table 120. Soft Gel Technologies Description and Major Businesses
Table 121. Soft Gel Technologies Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Soft Gel Technologies Product
Table 123. Soft Gel Technologies Recent Development
Table 124. Amway Corporation Information
Table 125. Amway Description and Major Businesses
Table 126. Amway Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Amway Product
Table 128. Amway Recent Development
Table 129. Sirio Pharma Corporation Information
Table 130. Sirio Pharma Description and Major Businesses
Table 131. Sirio Pharma Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Sirio Pharma Product
Table 133. Sirio Pharma Recent Development
Table 134. Baihe Biotech Corporation Information
Table 135. Baihe Biotech Description and Major Businesses
Table 136. Baihe Biotech Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Baihe Biotech Product
Table 138. Baihe Biotech Recent Development
Table 139. Ziguang Group Corporation Information
Table 140. Ziguang Group Description and Major Businesses
Table 141. Ziguang Group Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Ziguang Group Product
Table 143. Ziguang Group Recent Development
Table 144. Yuwang Group Corporation Information
Table 145. Yuwang Group Description and Major Businesses
Table 146. Yuwang Group Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Yuwang Group Product
Table 148. Yuwang Group Recent Development
Table 149. Donghai Pharm Corporation Information
Table 150. Donghai Pharm Description and Major Businesses
Table 151. Donghai Pharm Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Donghai Pharm Product
Table 153. Donghai Pharm Recent Development
Table 154. By-Health Corporation Information
Table 155. By-Health Description and Major Businesses
Table 156. By-Health Non-animal Capsule Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. By-Health Product
Table 158. By-Health Recent Development
Table 159. Global Non-animal Capsule Sales Forecast by Regions (2021-2026) (K Units)
Table 160. Global Non-animal Capsule Sales Market Share Forecast by Regions (2021-2026)
Table 161. Global Non-animal Capsule Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 162. Global Non-animal Capsule Revenue Market Share Forecast by Regions (2021-2026)
Table 163. North America: Non-animal Capsule Sales Forecast by Country (2021-2026) (K Units)
Table 164. North America: Non-animal Capsule Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Europe: Non-animal Capsule Sales Forecast by Country (2021-2026) (K Units)
Table 166. Europe: Non-animal Capsule Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Asia Pacific: Non-animal Capsule Sales Forecast by Region (2021-2026) (K Units)
Table 168. Asia Pacific: Non-animal Capsule Revenue Forecast by Region (2021-2026) (US$ Million)
Table 169. Latin America: Non-animal Capsule Sales Forecast by Country (2021-2026) (K Units)
Table 170. Latin America: Non-animal Capsule Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Middle East and Africa: Non-animal Capsule Sales Forecast by Country (2021-2026) (K Units)
Table 172. Middle East and Africa: Non-animal Capsule Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 174. Key Challenges
Table 175. Market Risks
Table 176. Main Points Interviewed from Key Non-animal Capsule Players
Table 177. Non-animal Capsule Customers List
Table 178. Non-animal Capsule Distributors List
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-animal Capsule Product Picture
Figure 2. Global Non-animal Capsule Sales Market Share by Type in 2020 & 2026
Figure 3. Type A (pH-9, Skin) Product Picture
Figure 4. Type B (pH-4.7, Bone) Product Picture
Figure 5. Global Non-animal Capsule Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceutical
Figure 7. Health Supplements
Figure 8. Others
Figure 9. Non-animal Capsule Report Years Considered
Figure 10. Global Non-animal Capsule Market Size 2015-2026 (US$ Million)
Figure 11. Global Non-animal Capsule Sales 2015-2026 (K Units)
Figure 12. Global Non-animal Capsule Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Non-animal Capsule Sales Market Share by Region (2015-2020)
Figure 14. Global Non-animal Capsule Sales Market Share by Region in 2019
Figure 15. Global Non-animal Capsule Revenue Market Share by Region (2015-2020)
Figure 16. Global Non-animal Capsule Revenue Market Share by Region in 2019
Figure 17. Global Non-animal Capsule Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Non-animal Capsule Revenue in 2019
Figure 19. Non-animal Capsule Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Non-animal Capsule Sales Market Share by Type (2015-2020)
Figure 21. Global Non-animal Capsule Sales Market Share by Type in 2019
Figure 22. Global Non-animal Capsule Revenue Market Share by Type (2015-2020)
Figure 23. Global Non-animal Capsule Revenue Market Share by Type in 2019
Figure 24. Global Non-animal Capsule Market Share by Price Range (2015-2020)
Figure 25. Global Non-animal Capsule Sales Market Share by Application (2015-2020)
Figure 26. Global Non-animal Capsule Sales Market Share by Application in 2019
Figure 27. Global Non-animal Capsule Revenue Market Share by Application (2015-2020)
Figure 28. Global Non-animal Capsule Revenue Market Share by Application in 2019
Figure 29. North America Non-animal Capsule Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Non-animal Capsule Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Non-animal Capsule Sales Market Share by Country in 2019
Figure 32. North America Non-animal Capsule Revenue Market Share by Country in 2019
Figure 33. U.S. Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Non-animal Capsule Market Share by Type in 2019
Figure 38. North America Non-animal Capsule Market Share by Application in 2019
Figure 39. Europe Non-animal Capsule Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Non-animal Capsule Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Non-animal Capsule Sales Market Share by Country in 2019
Figure 42. Europe Non-animal Capsule Revenue Market Share by Country in 2019
Figure 43. Germany Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Non-animal Capsule Market Share by Type in 2019
Figure 54. Europe Non-animal Capsule Market Share by Application in 2019
Figure 55. Asia Pacific Non-animal Capsule Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Non-animal Capsule Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Non-animal Capsule Sales Market Share by Region in 2019
Figure 58. Asia Pacific Non-animal Capsule Revenue Market Share by Region in 2019
Figure 59. China Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Non-animal Capsule Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Non-animal Capsule Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Non-animal C
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs